Literature DB >> 20865684

Recurrent ventricular arrhythmias and myocardial infarctions associated with cocaine induced reversible coronary vasospasm.

Aytul Belgi Yildirim1, Ibrahim Basarici, Murathan Kucuk.   

Abstract

Cocaine has become the most frequently used illicit drug among patients presenting to emergency departments worldwide. Although acute myocardial infarction is the most common reported cardiovascular manifestation in this setting, there are many other potential cardiotoxic effects of cocaine use including coronary artery spasm, arrhythmia, and sudden death. We report the case of a 54 year-old male with angiographically documented reversible coronary arterial spasm leading to severe life-threatening recurrent ventricular arrhythmias and electrocardiographic changes suggesting acute myocardial infarction secondary to cocaine use. Recurrent ventricular arrhythmias of this patient required implantation of a cardioverter-defibrillator which successfully treated following arrhythmia episodes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865684

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  Effect of intracoronary adenosine on ergonovine-induced vasoconstricted coronary arteries.

Authors:  Jun-Hyok Oh; Seunghwan Song; Changhoon Kim; Jinhee Ahn; Jin Sup Park; Hye Won Lee; Jung Hyun Choi; Han Cheol Lee; Kwang Soo Cha; Taek Jong Hong
Journal:  Cardiol J       Date:  2018-07-16       Impact factor: 2.737

2.  Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

3.  Sniff of coke breaks the heart: cocaine-induced coronary vasospasm aggravated by therapeutic hypothermia and vasopressors after aborted sudden cardiac death: a case report.

Authors:  Martin Manninger; Sabine Perl; Helmut Brussee; Gabor G Toth
Journal:  Eur Heart J Case Rep       Date:  2018-04-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.